Sequential unfolding of ankyrin repeats in tumor suppressor p16

Structure

Volumn 11, Issue 1, 2003, Pages 67-73

  Tang, Kit S ^a   Fersht, Alan R ^a   Itzhaki, Laura S ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

value analysis; Ankyrin; P16; Protein engineering; Protein folding; Tandem repeat

Indexed keywords

ANKYRIN; MUTANT PROTEIN; PROTEIN P16; SULFATE;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN STRUCTURE; WILD TYPE;

ANKYRIN REPEAT; CYCLIN-DEPENDENT KINASE INHIBITOR P16; HUMANS; MODELS, MOLECULAR; MUTATION; PROTEIN DENATURATION; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; UREA;

EID: 0037228879     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(02)00929-2     Document Type: Article

References (43)

1. Aves S.J., Durkacz B.W., Carr A., Nurse P. Cloning, sequencing and transcriptional control of the Schizosaccharomyces pombe cdc10 start gene. EMBO J. 4:1985;457-463.
2. Breeden L., Nasmyth K. Similarity between cell-cycle genes of budding yeast and fission yeast and the Notch gene of Drosophila. Nature. 329:1987;651-654.
3. Lux S.E., John K.M., Bennett V. Analysis of cDNA for human erythrocyte ankyrin indicates a repeated structure with homology to tissue-differentiation and cell-cycle control proteins. Nature. 344:1990;36-42.
4. INK4A. determination of solution structure and analyses of its interaction with cyclin-dependent kinase 4 Mol. Cell. 1:1998;421-431.
5. Gorina S., Pavletich N.P. Structure of the p53 tumor-suppressor bound to the ankyrin and SH3 domains of 53BP2. Science. 274:1996;1001-1005.
6. Huxford T., Huang D.B., Malek S., Ghosh G. The crystal structure of the IκB α/NF-κB complex reveals mechanisms of NF-κB inactivation. Cell. 95:1998;759-770.
7. Jacobs M.D., Harrison S.C. Structure of an IκB α/NF-κB complex. Cell. 95:1998;749-758.
8. Batchelor A.H., Piper D.E., de la Brousse F.C., McKnight S.L., Wolberger C. The structure of GABP alpha/beta. an ETS domain ankyrin repeat heterodimer bound to DNA Science. 279:1998;1037-1041.
9. Yang Y.W., Nanduri S., Sen S., Qin J. The structural basis of ankyrin-like repeat function as revealed by the solution structure of myotrophin. Structure. 6:1998;619-626.
10. Foord R., Taylor I.A., Sedgwick S.G., Smerdon S.J. X-ray structural analysis of the yeast cell cycle regulator Swi6 reveals variations of the ankyrin fold and has implications for Swi6 function. Nat. Struct. Biol. 6:1999;157-165.
11. Mandiyan V., Andreev J., Schlessinger J., Hubbard S.R. Crystal structure of the ARF-GAP domain and ankyrin repeats of PYK2-associated protein β EMBO J. 18:1999;6890-6898.
12. INK4 mutations. Nat. Struct. Biol. 5:1998;74-81.
13. Li J.N., Byeon I.J.L., Ericson K., Poi M.J., O'Maille P., Selby T., Tsai M.D. Tumor suppressor INK4. determination of the solution structure of p18(INK4C) and demonstration of the functional significance of loops in p18(INK4C) and p16(INK4A) Biochemistry. 38:1999;2930-2940.
14. INK4d. Nature. 389:1997;999-1003.
15. Baumgartner R., Fernandez-Catalan C., Winoto A., Huber R., Engh R.A., Holak T.A. Structure of human cyclin-dependent kinase inhibitor p19(INK4d). comparison to known ankyrin-repeat-containing structures and implications for the dysfunction of tumor suppressor p16(INK4a) Structure. 6:1998;1279-1290.
16. Serrano M., Hannon G.J., Beach D. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D-CDK4. Nature. 366:1993;704-707.
17. INK4b is a potential effector of TGF-β-induced cell-cycle arrest. Nature. 371:1994;257-261.
18. Hirai H., Roussel M.F., Kato J.Y., Ashmun R.A., Sherr C.J. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol. 15:1995;2672-2681.
19. Kamb A., Gruis N.A., Weaverfeldhaus J., Liu Q.Y., Harshman K., Tavtigian S.V., Stockert E., Day R.S. III, Johnson B.E., Skolnick M.H. A cell-cycle regulator potentially involved in genesis of many tumor types. Science. 264:1994;436-440.
20. Nobori T., Miura K., Wu D.J., Lois A., Takabayashi K., Carson D.A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature. 368:1994;753-756.
21. Hall M., Peters G. Genetic alterations of cyclins, cyclin-dependent kinases, and cdk inhibitors in human cancer. Adv. Cancer Res. 68:1996;67-108.
22. Marcotte E.M., Pellegrini M., Yeates T.O., Eisenberg D. A census of protein repeats. J. Mol. Biol. 293:1999;151-160.
23. Groves M.R., Barford D. Topological characteristics of helical repeat proteins. Curr. Opin. Struct. Biol. 9:1999;383-389.
24. Kobe B., Kajava A.V. When protein folding is simplified to protein coiling. the continuum of solenoid protein structures Trends Biochem. Sci. 25:2000;509-515.
25. Andrade M.A., Perez-Iratxeta C., Ponting C.P. Protein repeats. structures, functions and evolution J. Struct. Biol. 134:2001;117-131.
26. Sedgwick S.G., Smerdon S.J. The ankyrin repeat. a diversity of interactions on a common structural framework Trends Biochem. Sci. 24:1999;311-316.
27. Matouschek A., Kellis J.T. Jr., Serrano L., Fersht A.R. Mapping the transition state and pathway of protein folding by protein engineering. Nature. 342:1989;122-126.
28. Fersht A.R., Matouschek A., Serrano L. The folding of an enzyme. I. Theory of protein engineering analysis of stability and pathway of protein folding. J. Mol. Biol. 224:1992;771-782.
29. INK4a. Nature. 395:1998;237-243.
30. INK4d. Nature. 395:1998;244-250.
31. Kalus W., Baumgartner R., Renner C., Noegel A., Chan F.K.M., Winoto A., Holak T.A. NMR structural characterization of the CDK inhibitor p19(INK4d). FEBS Lett. 401:1997;127-132.
32. Renner C., Baumgartner R., Noegel A.A., Holak T.A. Backbone dynamics of the CDK inhibitor p19(INK4d) studied by 15N NMR relaxation experiments at two field strengths. J. Mol. Biol. 283:1998;221-229.
33. Zhang B., Peng Z.Y. A minimum folding unit in the ankyrin repeat protein p16(INK4). J. Mol. Biol. 299:2000;1121-1132.
34. Tang K.S., Guralnick B.J., Wang W.K., Fersht A.R., Itzhaki L.S. Stability and folding of the tumour suppressor protein p16. J. Mol. Biol. 285:1999;1869-1886.
35. Lopez-Hernandez E., Serrano L. Structure of the transition state for folding of the 129 aa protein CheY resembles that of a smaller protein, CI-2. Structure. 1:1996;43-55.
36. Villegas V., Martinez J.C., Aviles F.X., Serrano L. Structure of the transition state in the folding process of human procarboxypeptidase A2 activation domain. J. Mol. Biol. 283:1998;1027-1036.
37. Schymkowitz J.W.H., Rousseau F., Irvine L.R., Itzhaki L.S. The folding pathway of the cell-cycle regulatory protein p13suc1. clues for the mechanism of domain swapping Structure. 8:2000;89-100.
38. Serrano L., Matouschek A., Fersht A.R. The folding of an enzyme. III. Structure of the transition state for unfolding of barnase analysed by a protein engineering procedure. J. Mol. Biol. 224:1992;805-818.
39. Fersht A.R. A kinetically significant intermediate in the folding of barnase. Proc. Natl. Acad. Sci. USA. 97:2000;14121-14126.
40. Russo A.A., Tong L., Lee J.O., Jeffrey P.D., Pavletich N.P. Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16(INK4a). Nature. 395:1998;237-243.
41. Lee C., Schwartz M.P., Prakash S., Iwakura M., Matouschek A. ATP-dependent proteases degrade their substrates by processively unravelling them from the degradation signal. Mol. Cell. 7:2001;627-637.
42. Clarke J., Fersht A.R. Engineering disulfide bonds as probes of the folding pathway of barnase - increasing the stability of proteins against the rate of denaturation. Biochemistry. 32:1993;43322-43329.
43. Kraulis P.J. MOLSCRIPT - a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24:1991;946-950.